Patents by Inventor Jay Matthew West

Jay Matthew West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-PURPOSE NECK SUPPORT ASSEMBLY
    Publication number: 20220039559
    Abstract: A portable headrest assembly having a foldable, substantially planar, U-shaped platform assembly with an open proximal end. The platform assembly is adapted to support a padded assembly and a user's head. A foldable, portable stand assembly with a central support assembly is pivotally coupled to at least three laterally extendable leg assemblies adapted to support the inventive concept in a freestanding position. A telescoping rod assembly is disposed through the central support assembly of the portable stand assembly, the top end portion coupled to a longitudinally rotatable joint assembly. At least one first tightener and loosener assembly circumscribes the telescoping rod assembly, and at least one second tightener and loosener assembly is disposed through the longitudinally rotatable joint assembly, the joint and loosener assemblies designed to change and maintain the optimal height and angle of the foldable, substantially planar, U-shaped platform assembly.
    Type: Application
    Filed: April 8, 2021
    Publication date: February 10, 2022
    Inventor: JAY MATTHEW WEST
  • N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
    Patent number: 10640494
    Abstract: A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof: Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA).
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: May 5, 2020
    Assignee: NORTHEASTERN UNIVERSITY
    Inventors: Michael Malamas, Alexandros Makriyannis, Kumara Vadivel Subramanian, Kyle M. Whitten, Nikolai M. Zvonok, Jay Matthew West, Michael McCormack, Spiro Pavlopoulos
  • N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Their Use Thereof
    Publication number: 20180222894
    Abstract: A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof: Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA).
    Type: Application
    Filed: March 30, 2018
    Publication date: August 9, 2018
    Inventors: Michael Malamas, Alexandros Makriyannis, Kumara Vadivel Subramanian, Kyle M. Whitten, Nikolai M. Zvonok, Jay Matthew West, Michael McCormack, Spiro Pavlopoulos
  • N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
    Patent number: 9963444
    Abstract: A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA). The present technology is directed to compounds, compositions, and methods to inhibit N-acylethanolamine hydrolyzing acid amidase and to treat N-acylethanolamine hydrolyzing acid amidase mediated conditions in a subject.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: May 8, 2018
    Assignee: Northeastern University
    Inventors: Michael Malamas, Alexandros Makriyannis, Kumara Vadivel Subramanian, Kyle M. Whitten, Nikolai M. Zvonok, Jay Matthew West, Michael Mccormack, Spiro Pavlopoulos
  • N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Their Use Thereof
    Publication number: 20170114050
    Abstract: A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA). The present technology is directed to compounds, compositions, and methods to inhibit N-acylethanolamine hydrolyzing acid amidase and to treat N-acylethanolamine hydrolyzing acid amidase mediated conditions in a subject.
    Type: Application
    Filed: May 13, 2015
    Publication date: April 27, 2017
    Inventors: Michael Malamas, Alexandros Makriyannis, Kumara Vadivel Subramanian, Kyle M. Whitten, Nikolai M. Zvonok, Jay Matthew West, Michael Mccormack, Spiro Pavlopoulos